#emtriva

[pozmagazine]

FDA Approves Truvada-Like HIV Tablet Temixys

The Food and Drug Administration (FDA) has approved the dual-antiretroviral (ARV) combination tablet Temixys (lamivudine/tenofovir disoproxil fumarate), which is manufactured by South Korean biopharmaceutical company Celltrion Inc., Pulse reports.

The tablet, which is to be used in combination with at least one other ARV to treat HIV, is similar to Gilead Sciences’ Truvada (tenofovir disoproxil fumarate/emtricitabine). They both contain tenofovir disoproxil fumarate, which is manufactured as an individual tablet under the brand name Viread and is a nucleoside/nucleotide reverse transcriptase inhibitor (NRTI). The second medications in each tablet are also NRTIs: Lamivudine (brand name Epivir) is in Temixys, and emtricitabine (brand name Emtriva) is in Truvada.

[pozmagazine]

HIV Treatment Linked to Faster Kidney Function Decline Among Men

Men living with HIV who are on antiretroviral (ARV) treatment experience faster decline in their kidney function compared with HIV-negative men, aidsmap reports.

Publishing their findings in the journal AIDS, researchers studied data from the Multicenter AIDS Cohort on 917 HIV-positive men on ARVs, 159 HIV-positive men not on ARVs and 1,305 HIV-negative men. The study period ran from October 2003 to September 2014.

[at2wblog]

AIDS Drug Truvada Says May Prevent Virus That Causes The Disease

via atoast2wealth.com

Federal drug regulators on Tuesday affirmed landmark study results showing that a popular HIV-fighting pill can also help healthy people avoid contracting the virus that causes AIDS in the first place. While the pill appears safe and effective for prevention, scientists stressed that it only works when taken on a daily basis.

http://www.atoast2wealth.com/2012/05/23/aids-drug-truvada-says-may-prevent-vi...